日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Bioequivalence and Safety Assessment of Brivaracetam Dry Syrup Compared With Tablets in Healthy Japanese Participants: Results From Two Randomized Single- and Multiple-Dose Trials

布瓦西坦干糖浆与片剂在健康日本受试者中的生物等效性和安全性评价：两项随机单剂量和多剂量试验的结果

期刊:Clinical Pharmacology in Drug Development
影响因子:1.8
doi:10.1002/cpdd.70057
Hayakawa, Yoshinobu; Yoshinaka, Ryoji; Sano, Tomonobu; Krauwinkel, Walter; Soma, Tadaharu; Sasamoto, Hiroshi; Elshoff, Jan-Peer; Bass, Almasa; Chen, Ying; Kurihara, Nozomi; Murakami, Harumi
发表日期：2026
文献求助 收藏

Efficacy, safety, and tolerability of adjunctive brivaracetam in adult Asian patients with uncontrolled focal-onset seizures: A phase III randomized, double-blind, placebo-controlled trial

布瓦西坦辅助治疗对亚洲成年难治性局灶性癫痫患者的疗效、安全性和耐受性：一项 III 期随机、双盲、安慰剂对照试验

期刊:Epilepsia Open
影响因子:2.9
doi:10.1002/epi4.12929
Inoue, Yushi; Tiamkao, Somsak; Zhou, Dong; Cabral-Lim, Leonor; Lim, Kheng Seang; Lim, Shih-Hui; Tsai, Jing-Jane; Moseley, Brian; Wang, Lin; Sun, Weiwei; Hayakawa, Yoshinobu; Sasamoto, Hiroshi; Sano, Tomonobu; McClung, Carrie; Bass, Almasa
癫痫
神经科学
发表日期：2024
文献求助 收藏

Effects of intravenous oxycodone alone or in combination with naltrexone on measures of respiratory depression: a randomized placebo-controlled study

单独静脉注射羟考酮或与纳曲酮联合静脉注射对呼吸抑制指标的影响：一项随机安慰剂对照研究

期刊:Therapeutic Advances in Drug Safety
影响因子:3.4
doi:10.1177/2042098618821274
Bass, Almasa; Webster, Lynn R; Matschke, Kyle T; Malhotra, Bimal K; Wolfram, Gernot
发表日期：2019
文献求助 收藏

Effect of Food on the Pharmacokinetics of Ertugliflozin and Its Fixed-Dose Combinations Ertugliflozin/Sitagliptin and Ertugliflozin/Metformin

食物对厄格列净及其固定剂量复方制剂（厄格列净/西格列汀和厄格列净/二甲双胍）药代动力学的影响

期刊:Clinical Pharmacology in Drug Development
影响因子:1.8
doi:10.1002/cpdd.629
Sahasrabudhe, Vaishali; Fediuk, Daryl J; Matschke, Kyle; Shi, Haihong; Liang, Yali; Hickman, Anne; Bass, Almasa; Terra, Steven G; Zhou, Susan; Krishna, Rajesh; Dawra, Vikas K
发表日期：2019
文献求助 收藏

Bioequivalence of Ertugliflozin/Sitagliptin Fixed-Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components

艾格列净/西格列汀固定剂量复方片剂的生物等效性及其各组分不同规格联合用药的生物等效性

期刊:Clinical Pharmacology in Drug Development
影响因子:1.8
doi:10.1002/cpdd.722
Fediuk, Daryl J; Matschke, Kyle; Liang, Yali; Pelletier, Kathleen B; Wei, Hua; Shi, Haihong; Bass, Almasa; Hickman, Anne; Terra, Steven G; Zhou, Susan; Krishna, Rajesh; Sahasrabudhe, Vaishali
发表日期：2019
文献求助 收藏

Pharmacokinetics, pharmacodynamics, and safety of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, in healthy subjects when administered in co-mixture with recombinant human hyaluronidase: A phase 1 randomized trial

在健康受试者中，博可珠单抗（一种针对前蛋白转化酶枯草杆菌蛋白酶/kexin 9 型的单克隆抗体）与重组人透明质酸酶联合给药时的药代动力学、药效学和安全性：一项 1 期随机试验

期刊:Health Science Reports
影响因子:2.1
doi:10.1002/hsr2.61
Bass, Almasa; Plotka, Anna; Mridha, Khurshid; Sattler, Catherine; Kim, Albert M; Plowchalk, David R
单克隆抗体
发表日期：2018
文献求助 收藏

Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients.

细胞色素 P450 衍生的二十碳酸类物质与冠状动脉疾病患者的血管功能障碍

期刊:Atherosclerosis
影响因子:5.7
doi:10.1016/j.atherosclerosis.2013.01.034
Schuck Robert N, Theken Katherine N, Edin Matthew L, Caughey Melissa, Bass Almasa, Ellis Kyle, Tran Bryant, Steele Savanna, Simmons Brian P, Lih Fred B, Tomer Kenneth B, Wu Michael C, Hinderliter Alan L, Stouffer George A, Zeldin Darryl C, Lee Craig R
细胞生物学
血管生成
发表日期：2013
文献求助 收藏

Relation between digital peripheral arterial tonometry and brachial artery ultrasound measures of vascular function in patients with coronary artery disease and in healthy volunteers

冠状动脉疾病患者和健康志愿者中，数字外周动脉张力测定法与肱动脉超声测量血管功能的关系

期刊:American Journal of Cardiology
影响因子:2.1
doi:10.1016/j.amjcard.2011.10.023
Lee, Craig R; Bass, Almasa; Ellis, Kyle; Tran, Bryant; Steele, Savanna; Caughey, Melissa; Stouffer, George A; Hinderliter, Alan L
发表日期：2012
文献求助 收藏